Cohort study based on the seventh edition of the TNM classification for gastric cancer: Proposal of a new staging system

Journal of Clinical Oncology

Volumn 29, Issue 17, 2011, Pages 2364-2371

  Warneke, Viktoria S ^a   Behrens, Hans Michael ^a   Hartmann, Jörg T ^a   Held, Harald ^b   Becker, Thomas ^a   Schwarz, Nicolas T ^b   Röcken, Christoph ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Friedrich Ebert Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 79959266531     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.34.4358     Document Type: Article

References (28)

1. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781, 2010
2. Ferlay J, Shin HR, Bray F, et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
3. Cheong O, Oh ST, Kim BS, et al: Large metastatic lymph node size, especially more than 2 cm: Independent predictor of poor prognosis in node-positive gastric carcinoma. World J Surg 32:262-266, 2008
4. Gotoda T, Yanagisawa A, Sasako M, et al: Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two large centers. Gastric Cancer 3:219-225, 2000 (Pubitemid 32290729)
5. Hohenberger P, Gretschel S: Gastric cancer. Lancet 362:305-315, 2003 (Pubitemid 36936845)
6. Lordick F, Grenacher L, Röcken C, et al: Diagnosis and treatment of gastric cancer. Dtsch Med Wochenschr 135:1671-1682, 2010
7. Marchet A, Mocellin S, Ambrosi A, et al: The prognostic value of N-ratio in patients with gastric cancer: Validation in a large, multicenter series. Eur J Surg Oncol 34:159-165, 2008
8. Baiocchi GL, Tiberio GA, Minicozzi AM, et al: A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252:70-73, 2010
9. Marchet A, Mocellin S, Ambrosi A, et al: The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: Results from an Italian multicentric study in 1853 patients. Ann Surg 245:543-552, 2007
10. Alberts SR, Cervantes A, Van de Velde CJ: Gastric cancer: Epidemiology, pathology and treatment. Ann Oncol 14::ii31-ii36, 2003 (suppl 2)
11. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
12. Paoletti X, Oba K, Burzykowski T, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA 303:1729-1737, 2010
13. Bang YJ, Van CE, Feyereislova A, et al: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 376:687-697, 2010
14. Wittekind C, Meyer H-J: TNM Classification of Malignant Tumours (ed 7). Weinheim, Germany, Wiley, 2010
15. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinaltype carcinoma - An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49, 1965
16. Wittekind C, Tannapfel A: The current TNM system for gastrointestinal tumors part I. Pathologe 31:344-347, 2010
17. Rüschoff J, Dietel M, Baretton G, et al: HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch 457:299-307, 2010
18. Rausei S, Dionigi G, Boni L, et al: How does the 7th TNM edition fit in gastric cancer management? Ann Surg Oncol 10.1245/s10434-010-1346-z 2010 [epub ahead of print on September 29, 2010]
19. Wittekind C: TNM 2010: What's new? Pathologe 31:153-160, 2010 (suppl 2)
20. Wittekind C, Meyer H-J, Bootz F: TNM Classification of Malignant Tumours (ed 6). Berlin, Springer, 2002
21. Wittekind C, Oberschmid B: Gastrointestinal tumors: New N classification of the UICC. Chirurg 81:95-98, 100-102, 2010
22. International Union Against Cancer: Homepage. http://www.uicc.org/ resources/tnm
23. Siewert JR, Fink U, Sendler A, et al: Gastric Cancer. Curr Probl Surg 34:835-939, 1997
24. Adachi Y, Yasuda K, Inomata M, et al: Pathology and prognosis of gastric carcinoma: Well versus poorly differentiated type. Cancer 89:1418-1424, 2000
25. Dassen AE, Lemmens VE, van de Poll-Franse LV, et al: Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands. Eur J Cancer 46:1101-1110, 2010
26. Nitti D, Marchet A, Mocellin S, et al: Prognostic value of subclassification of T2 tumours in patients with gastric cancer. Br J Surg 96:398-404, 2009
27. Novotny AR, Schuhmacher C, Busch R, et al: Predicting individual survival after gastric cancer resection: Validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg 243:74-81, 2006 (Pubitemid 43054057)
28. Siewert JR, Bottcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461, 1998 (Pubitemid 30194389)